Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomipramine for fatigue in long COVID
jRCTs031240334Recruiting
- Sponsor
- Psychiatric and Neurological Disorders Research and Development Fund
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of clomipramine in post-COVID syndrome (3 arms), sponsored by Psychiatric and Neurological Disorders Research and Development Fund. Started Feb 2025; status: recruiting.
02
Drugs
clomipramine
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on jRCTs031240334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240334.